BLTE
Belite Bio Inc
165.90$
-0.8%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Belite Bio Inc (BLTE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -4.4 | -7.5 | -11 | -30 | -29 | -37 | |
| 0.0 | 0.0 | 0.2 | 0.4 | 0.4 | 0.5 | |
| 1.4 | 1.5 | 1.5 | 3.8 | 9.0 | 39 | |
| 1.4 | 1.5 | – | – | – | – | |
| -0.1 | 0.6 | -0.5 | -2.4 | 1.1 | 2.6 | |
| 0.0 | 0.1 | 0.4 | 0.1 | 0.2 | 0.2 | |
| 0.0 | -0.1 | -0.4 | -0.1 | -111 | -305 | |
| -2.3 | 0.0 | 0.0 | – | – | – | |
| 28 | -0.6 | 37 | 76 | 84 | 663 | |
| 24 | -8.3 | 25 | 46 | -56 | 321 | |
| -4.5 | -7.5 | -12 | -30 | -29 | -37 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.